Medication info

Bonvianjeong 20mg (Bazedoxifene Acetate)

Prescription medicationTabletOralExpired
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
White or grayish capsule-shaped film-coated tablets
Packaging
28 tablets (28 tablets/PTP)
Approval status
Expired

MFDS item code 201902181 · Approved 2019.04.10

This product's status changed to Expired on 2024.04.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily (equivalent to 20mg bazedoxifene), with or without food. If the patient's dietary intake of calcium and vitamin D is inadequate, supplements should be taken. Patients with renal impairment: This drug should be administered with caution in patients with severe renal impairment, as it has not been adequately evaluated in this population. No dose adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment, as its safety and efficacy have not been established.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • spinal fractures
View approved original text

This medication is used to treat and prevent osteoporosis in postmenopausal women. It is particularly effective in reducing the occurrence of spinal fractures. However, its effect on non-spinal fractures has not been definitively proven. Therefore, it is mainly used to mitigate the risk of spinal-related fractures. It contributes to improving skeletal health as a medication that helps manage osteoporosis.

How to take

Adult dose

Take 1 tablet once daily (equivalent to 20mg bazedoxifene), with or without food. If the patient's dietary intake of calcium and vitamin D is inadequate, supplements should be taken. Patients with renal impairment: This drug should be administered with caution in patients with severe renal impairment, as it has not been adequately evaluated in this population. No dose adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: Use of this drug is not recommended in patients with hepatic impairment, as its safety and efficacy have not been established.

Precautions

This medication may increase the risk of blood clotting disorders, such as venous thromboembolism. Women with a history of or risk factors for deep vein thrombosis, pulmonary embolism, or retinal vein thrombosis should avoid using this medication. This medication is intended only for postmenopausal women and should not be used by premenopausal women, those who are pregnant, or those who are breastfeeding. Women who might become pregnant should also not take this medication. While this medication does not induce endometrial hyperplasia, if any uterine bleeding occurs during treatment, it is essential to seek medical attention. Furthermore, its safety in breast cancer patients has not been adequately studied, so it should not be used for the prevention or treatment of breast cancer. Patients with hypersensitivity to this medication or a history of venous thromboembolism, unexplained uterine bleeding, symptoms of endometrial cancer, and rare genetic diseases such as lactose intolerance should not take this medication. Patients with hypertriglyceridemia or severe renal or liver dysfunction should use this medication with caution. In particular, in patients with severe liver dysfunction, blood levels of this medication may significantly increase, so it is not recommended. This medication may cause side effects such as facial flushing, leg cramps, drowsiness, dry mouth, rash, itching, muscle cramps, elevated blood triglycerides, elevated alanine aminotransferase (ALT), elevated aspartate aminotransferase (AST), vision impairment, blurred vision, photophobia, visual field defects, visual disturbances, dry eyes, eyelid swelling, eyelid spasms, pain in the eyes, and if these symptoms are severe, consultation with a doctor is necessary. Particularly, if visual disturbances or eye-related symptoms occur, immediate medical attention should be sought. When driving or operating machinery, caution is required due to the risk of accidents from drowsiness or visual disturbances. If these symptoms are present, care should be taken. The potential for drug interactions with this medication is low; however, the concentrations of some medications may change when taken concurrently, so if other medications are being taken, consultation with a doctor or pharmacist is recommended. In case of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms. This medication should be kept out of reach of children and stored in its original container for safety.

Side effects

  • hypersensitivity
  • drowsiness
  • retinal vein thrombosis
  • facial flushing
  • deep vein thrombosis
  • superficial venous thrombophlebitis
  • pulmonary embolism
  • dry mouth
  • urticaria
  • rash
Show 16 more
  • itching
  • muscle cramps
  • peripheral edema
  • elevated triglycerides
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • vision impairment
  • blurred vision
  • photopsia
  • visual field defects
  • visual disturbances
  • dry eye syndrome
  • eyelid edema
  • eyelid spasm
  • eye pain
  • swollen eyes

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best stored in a cool place below 25 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White or grayish capsule-shaped film-coated tablets

Package unit

28 tablets (28 tablets/PTP)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.